Gene Editing in Stem Cells: Next-Generation Stem Cell Therapies

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Stem Cells".

Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 194

Special Issue Editor

E-Mail Website
Guest Editor
Center for Genomics and Proteomics, School of Medicine, Gachon University, Incheon 406-840, Republic of Korea
Interests: stem cell CRISPR editing; stem cell therapeutics; allogeneic manufacturing; CAR-T/NK cells; stem cell proteomics/genomics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, thousands of proteins have been identified as being associated with complex and rare diseases caused by a wide range of genetic mutations, involving single nucleotide polymorphisms, deletions, duplications and insertions of nucleotides or whole genes, as well as chromosomal rearrangements and gene rearrangements. As for the utilization of next-generation therapeutic approaches to incurable diseases, the integration of gene editing technologies and stem cells appears to hold considerable promise. In light of the boundless potential and demand for gene-edited stem cell therapies, this field of research has evolved in a variety of ways, including the discovery of new gene editing platforms, the development of advanced technologies for safe in vivo and ex vivo cell editing, and the successful homing of transplanted cells. Throughout this Special Issue of Cells, we aim to provide readers with the most up-to-date information on this fascinating subject.

Prof. Dr. Bonghee Lee
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • gene editing
  • stem cells
  • CRISPR/Cas system
  • ZFN

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop